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ABSTRACT 
Various novel drug delivery systems have been developed encompassing several administration routes to deliver drugs at a rate decided as per the 
need of the body during the course of treatment and to achieve targeted therapy, also decreases undesirable side effects. Different types of vesicular 
drug delivery systems were developed, such as liposomes, niosomes, ufasomes etc. Ufasomes are unsaturated fatty acid vesicles which is a 
suspension of closed lipid bilayer formed from fatty acid and their ionized species having limited, narrow pH ranging from 7-9. Composition of fatty 
acid molecules is such that the hydrocarbon tails are pointed towards the inner core of the membrane and the carboxyl group are in touch with 
water. Stable ufasomes preparation mainly relies on appropriate choice of fatty acid, cholesterol quantity, range of the pH, buffer and lipoxygenase 
amount. Recent innovation provides very efficient features such as stability considerations, dynamic features and microscopic features of ufasomes. 
The article furthermore provides the difference between ufasomes with liposomes. For this review, the complete databases have been collected 
from various search engines such as researchgate, elsevier, pubmed, sciencedirect, google scholar, scopus etc., from the year 1965-2020 using the 
following keywords. 
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INTRODUCTION 
In the developing delivery system, a novel drug delivery system has 
proved to be the most fulfilling and approachable to accomplish the 
targeted and controlled drug delivery. Target drug delivery is a 
technique in which the therapeutic agents are delivered to the tissue 
of interest and relatively diminishing the concentration of the 
therapeutic agent in other tissues, which higher the concentration of 
drug at the target site and with less side effect [1, 2]. Paul Ehrlich in 
1909, first produced the target drug delivery system, in which target 
drugs are directly delivered to the unhealthy cells. Afterward, the 
number of novel vesicular drug delivery system aims to convey the 
pharmaceutical compound in the body at a rate coordinated as per 
the need of the body during the treatment period and securely 
accomplish its desired therapeutic effect. In the previous few 
decades, the advancement of the new drug delivery system has 
gained extensive consideration [3]. Bingham first announced the 
biological origin of these vesicles in 1965 and has been given the name 
‘Bingham bodies' [4]. The novel drug delivery system is focused to 
satisfy two requirements that it ought to deliver drugs at a rate 
directed as per the need of the body over the treatment period and to 
convey the medication straightforwardly to the injured tissue, 
receptor or organ. For the targeted therapy number of carriers was 
utilized to deliver the drug, which includes immunoglobulins, serum 
proteins, synthetic polymers, particulate systems (fig. 1). Colloidal 
carrier system is the other name of the particulate system which 
includes microspheres, lipid particles-high density lipoprotein (HDL) 
and low-density lipoprotein (LDL), polymeric micelles, nanoparticles 
and vesicular carriers such as liposomes, niosomes, ufasomes, 
ethosomes and so forth [5, 6]. In which vesicular drug delivery system 
is the most noticeable among the carriers. In vesicular drug delivery, 
there is improved bioavailability of medication with reduced expense 
of therapy, mainly in the case of drug with less solubility. Also, both 
lipophilic and hydrophilic drugs can be incorporated [7, 8]. 
Different novel methodology for delivering drugs by the vesicular 
system were developed, which includes liposomes, aquasomes, 
ethosomes, sphingosomes, bilosomes, transferosomes, virosomes, 
niosomes, ufasomes [9]. 
Advantages of vesicular drug delivery system  
• Delays elimination of quickly metabolizable drugs. 
• Presence of drugs in systemic circulation can be prolonged. 
• Certain medications with toxicity issues can be resolved. 
• Both lipophilic and hydrophilic drugs can be incorporated easily. 
• Improving bioavailability of drugs particularly in the case of 
poorly soluble drugs. 
• Issues like drug insolubility, instability and rapid disintegration 
can be controlled. 
• Lessens the cost of treatment [10]. 
 
 
Fig. 1: Pharmaceutical carriers [11] 
 
Classification of vesicular drug delivery system (VDDS) 
The vesicles are grouped on the basis of their composition [12] 
• Lipoidal Biocarriers 
• Nonlipoidal Biocarriers. 
Lipoidal biocarriers as VDDS 
Liposomes 
Liposomes are concentric bilayered vesicle which is tiny 
(unilamellar or multilamellar), where the fluid compartment is 
entirely encased by a bilayered membrane, made out of natural or 
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synthetic lipids. In liposomal drug delivery system, 
phosphatidylcholine and cholesterol are the essential components 
[13]. Liposomes have the capacity to entrap compounds of different 
solubility due to their alternating hydrophilic and hydrophobic 
structure. 
Liposomes are capable of entrapping compounds with varying 
solubilities because of their alternating structure [14] and therefore 
can entrap hydrophilic and lipophilic drugs can be entrapped into 
liposomes. In targeted delivery of drugs, Liposomes are considered 
as a potential drug carrier. Liposomes is an efficient drug delivery 
system with enhanced biodegradability, high cell or tissue specificity 
and in intranasal liposomal delivery, drug degradation due to 
enzymes are well protected and allow the drug to pass through 
blood-brain barrier [15]. Some of the constraints of liposomes are 
high expense, spillage and fusion of the encapsulated drug. Short 
half-life, low solvency and stability.  
Emulsomes  
Emulsomes is a lipoidal drug delivery system. Principally intended 
for parenteral delivery of drug having a poor water solubility. Fats 
and triglycerides comprise the main part of the interior core and are 
stabilized in the form of oil in water emulsion by the addition of a 
high concentration of lecithin. It has the quality of both liposomes 
and emulsion. Medicaments can be delivered through several routes 
such as oral, parenteral, topical, rectal ocular and intranasal as 
emulsomes. Advantages of emulsomes include improved 
biodegradability, biocompatibility, sustained release of drugs, 
increased entrapment efficiency, gastrointestinal tract stability [16]. 
Ethosomes 
Ethosomes have been intended for delivering drugs having high 
penetration power through the skin as well as systemic circulation. 
Ethosomes are made up of phospholipids (phosphatidylcholine, 
phosphatidylserine, phosphatitidic acid), alcohol (ethanol, isopropyl 
alcohol) in relatively high concentration and water. The high ethanol 
concentration makes the ethosomes capable of better penetration 
through the skin [17]. Ethosomes are utilized for the delivery of 
huge and diverse group of medicaments like antifungal agents, 
antiviral agents, nonsteroidal anti-inflammatory drugs, antibiotics 
and various other drugs like propanolol, testosterone, etc. One of the 
main advantage of ethosomes include the targeted delivery of drugs 
through the skin for transdermal and dermal delivery [2]. 
Transferosomes  
Transferosomes have high vesicle deformability which is its unique 
property and gives better penetration of intact vesicle and have both 
hydrophilic and hydrophobic properties. They are stress-responsive 
and possess a complex vesicle with a complex lipid bilayer with an 
aqueous core [18] for the controlled and targeted delivery of drugs 
like peptides and hormones, transferases are predominantly used as 
carrier. Due to the brutal condition of the gastrointestinal tract and 
due to rapid degradation and instability of insulin and interferon in 
the stomach, oral delivery of peptides is not possible. In this manner, 
biogenic molecules such as vaccines, insulin can be administered 
through transferosomes without any degradation. 
Sphingosomes  
Sphingosomes have been introduced to overcome certain stability 
problems related with liposomes, such as oxidation, hydrolysis, 
degradation, leaching, sedimentation, drug aggregation. This 
prompted to the development of sphingosomes [19]. Here 
sphingolipids are present rather than phospholipids in liposomes, in 
this way the name sphingosomes. Sphingosomes are colloidal, 
concentric bilayered vesicle having a lipid bilayered film which 
encloses the aqueous volume in it and is mainly made up of natural 
or synthetic sphingolipids. Points of interest of sphingosomes 
include: better drug retention is the main point of interest in the 
case of sphingosomes. There are several routes by which they can be 
administered, such as oral, intravenous, intra-arterial, subcutaneous, 
intramuscular and so on [20]. Therapeutic index and efficacy of the 
encapsulated drugs are expanded and the danger of encapsulated 
drugs is also decreased. 
Pharmacosomes  
Pharmacosomes means drug carrier as ‘pharmacon’ signifies drug 
and ‘soma’ signifies carrier. Pharmacosomes are novel vesicular 
drug delivery system and have remarkable properties over other 
drug delivery system. Pharmacosomes are amphiphilic lipid 
vesicular system formed by the colloidal dispersion of drugs and for 
increasing the bioavailability of poorly water-soluble drug and 
poorly lipophilic drug, it is covalently bound to lipids [21]. Drug, 
solvent and lipids are the three components required for the 
preparation of pharmacosomes. 
Spillage of the drug doesn’t occur, as the drugs are covalently 
conjugated with lipids and consequently provides maximum 
entrapment efficiency. 
Enzymosomes  
It is a supramolecular vesicular drug delivery system. Numerous 
approaches like polymeric carriers can be adopted for the delivery of 
therapeutic proteins such as enzymes. Enzymosomes are generated by 
complexing enzymes with lipids. A prominent response was shown in 
the antibody release on the target site, by coupling covalently on the 
surface of liposomes. Enzymosomes shows increased stability and 
encapsulation. This increased therapeutic effect and lower side effect by 
carrying the therapeutic agent to the destined tissue receptor, while 
maintaining enzymatic activity in intact form [22]. 
Non-lipoidal biocarriers as VDDS 
Aquasomes  
The Nanobiotechnology, i.e., the blend of biotechnology and 
nanotechnology has proposed another methodology as aquasomes as a 
solution to overcome the serious side effects associated with the 
bioengineered molecules such as peptide, hormone, protein. Aquasome 
is a three-layered self-assembled nanostructure compositions with 
ceramic carbon nanocrystalline particulate core covered with oligomeric 
film (made up of carbohydrates) on which biochemically active 
molecules are adsorbed by copolymerization, diffusion or absorption 
with alteration or not [23]. The structural stability is maintained by a 
solid core and the carbohydrate coating protects from dehydration and 
stimulates the biochemically active molecules. 
Niosomes  
Niosomes is a bilayered vesicle composed of non-ionic surface active 
agents. It is formed by the hydration of non-ionic surfactants for eg. 
Polygycerolalkyl ether, polyoxyethylenealkyl ether, glucosyldialkyl ether, 
etc. is added to cholesterol in aqueous media. Niosomes are mostly 
unilamellar or multilamellar vesicles and are small and microscopic in 
structure and size ranges from 10-1000 nm [24]. Entrapment efficacy of 
niosome is increased by the addition of non-ionic surfactant that also 
increases the size of the vesicle and also gives a charge to the vesicle. 
Non-ionic surfactants are used as it cause less irritation. Niosomes have a 
structure similar to that of liposomes and niosomes can entrap both 
hydrophilic and hydrophobic drug which can be delivered through 
different routes such as oral, parenteral, transdermal etc [25]. Also, 
niosomes are used as an alternative to liposomes for targeted drug 
delivery. Recently nisosomes have shown better efficacy in transdermal 
delivery of drugs. 
Bilosomes  
Bilosomes is a novel drug delivery carrier that consists of a 
membrane of niosomes incorporated with deoxycholic acid. In the 
gastrointestinal tract, dissolution and enzymatic degradation occurs 
in the case of conventional vesicles like liposomes and niosomes but 
in niosomal formulation when bile salt is incorporated could 
stabilize the membrane from the harmful effect of bile acid in 
gastrointestinal tract [26]. Bilosomes are therefore known as bile 
salt stabilized vesicle. Since they are highly stable in the 
gastrointestinal tract, they have increased biocompatibility and 
improved therapeutic efficacy of the drug. Bilosomes are found to 
have increased bioavailability as they are readily absorbed from the 
small intestine and are carried to the portal circulation. Through the 
hepatocirculation, they reach the liver and release the drug and is 
found to be effective in liver targeted drug delivery. 
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Ufasomes-as vesicular drug carrier 
Ufasomes are unsaturated fatty acid vesicles that are closed lipid 
bilayered suspension, which are made from unsaturated fats and 
their ionized species (soap), where pH is limited and ranging from 7 
to 9. Fatty acid vesicles generally have two types of amphiphiles, 
non-ionic neutral form and the other is ionized form (negatively 
charged soap) (fig. 2). The basic for vesicle stability is determined by 
non-ionic neutral and ionic form ratio. Gebicki and Hicks in 1973 
first reported fatty acid vesicles formation and also oleic and linoleic 
acid in the following years, and the vesicles formed was initially 
named as ufasomes [27, 28]. But later investigation shown that not 
only unsaturated fatty acid forms fatty acid vesicles, but also 
octanoic and decanoic acid-like saturated fatty acid can form fatty 
acid vesicle. One important feature of ufasomes are that the fatty 
acids are readily available and they are composed of single-chain 
amphiphiles [29, 30]. Whereas phospholipids are used in the 
formulation of liposomes, but reasonable quantity of pure synthetic 




Fig. 2: Structure of ufasomes [31] 
 
Advantages 
• Ufasomes are stable than liposomes. 
• Ufasomes have better entrapment efficiency for hydrophilic and 
hydrophobic drugs. 
• Ufasomes are cheaper than liposomes. 
• Easy to prepare. 
• Therapeutic viability. 
• Ready availability of fatty acid for ufasomal composition. 
• Ufasomes are capable as carriers for oral intake of less 
absorbable drugs. 
• Easy penetration of the drug in case of topical application.  
• Ufasomes have better drug retention along with sustained 
release in the deeper layer of skin for long-term effect in the case of 
topical application. 
• Potential carrier for anti-inflammatory for anti-inflammatory 
drug delivery. 
Disadvantages 
• Ufasomes are readily oxidized leading to stability problems in 
fatty drug products. 
• Some products produced during oxidation may be toxic. 
• Colloidal instability of ufasomes affects their application in food 
additives and drug delivery. 
• Risk of atherosclerosis [32]. 
Method of preparation of ufasomes 
Practically for the preparation of either type of vesicles almost 
identical techniques can be used. 
But for the preparation of ufasomes only unoxidized materials are 
preferred. Stock solution is prepared which contains 10 % oleic acid 
and linoleic acid in chloroform and stored under 20 °C. In a typical 
preparation, test tube containing 0.02 ml of the stock solution is 
taken and the stock solution is evaporated in a water pump and with 
the nitrogen steam it is finally dried. The film fatty acid is totally 
broken in 0.2 ml of 0.1 M tri-hydroxymethyl aminomethane buffer at 
8 to 9 pH range, on a vortex mixer by vigorous shaking. Thus, the 
ufasome suspension formed as a result of mixing are stable for 
minimum 24 h. In some experiments, particles are prepared by an 
ultrasonic generator with a microtip. By steam of nitrogen, air is first 
removed from the buffer and the suspension is overlaid with the gas 
during irradiation. Using ice bath, consistent temperature is kept up 
[30, 33]. The additives used in the preparation of ufasomes are 
depicted (table 1). 
 
Table 1: Additives used in ufasome preparation 
S. No. Class Example Uses Reference 
1. Fatty Acids 10 % oleic and linoleic acid Vesicle forming component [34] 
2. Solvents 1. Chloroform 
2. Stream of nitrogen 
1. For maintaining membrane permeability 
2. Drying of preparation 
3. Buffering agents Tris-hydroxymethyl aminomethane buffer (pH 8-9) As hydrating medium 
 
Key issues in manufacturing ufasomes  
Selection of fatty acid 
Fatty acid surface film-based analysis and information studies suggest 
that for the formulation of stable ufasomes, 12 to 22 carbon fatty acid 
will be appropriate. Studies were very limited since C-18 fatty acids 
demonstrated the best guarantee in the early tests. Only membrane 
made from oleic unsaturated fatty acid (cis-9-octadecenoic acid) and 
linoleic unsaturated fatty acid (cis, cis-9, 12-octadecadienoic acid) are 
only preferable in the preparation of ufasomes. There is no 
improvement in ufasome preparation on charging the membrane with 
little quantity of oleic, linoleic and stearic acid. Oleic acid remains 
uncontaminated for a minimum of six weeks, whereas significant 
peroxides were developed after two to three weeks in the case of 
peroxides and were interpreted by stability tests [30]. 
Addition of cholesterol 
Cholesterol serves a unique property in the case of vesicles prepared 
from lipids, such that cholesterol modulates membrane fluidity, 
flexibility and permeability like purpose. Cholesterol is used for 
filling gaps formed due to defective packing of other lipid species. 
But there is a fast decrease in the capacity of the vesicle to hold 
solute in the presence of higher extent of cholesterol. Also, at any 
cholesterol concentrations there is no upgrade in membrane 
impermeability. Hicks et al., compared the leakage of glucose from 
ufasomes made of oleic acid and linoleic acid with spheres 
incorporated with 17 % of cholesterol by weight. From the result it 
was understood that the leakage of glucose from spheres 
incorporated with 17 % of cholesterol by weight showed higher 
leakage than the oleic and linoleic acid ufasomes [30, 33]. 
pH range 
Generally, for the formulation of fatty acid vesicle pH is restricted to 
a very narrow range 7 to 9, half of the carboxylic acids are ionized. 
Fatty acid under the pH range 7 is called unsaturated fatty acid. Also, 
below this particular range it frames only unstructured precipitates, 
whereas above this range they are excessively soluble. At higher pH, 
dominant aggregation species are called micelles and at lower pH 
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region oil droplets forms. ‘Critical vesiculation concentration’ (CVS) 
is the fatty acid vesicle systems at concentrations slightly over the 
concentration where the formation of vesicles takes place. Colloidal 
suspension of vesicles is formed at CVS where non-vesicular 
aggregates and monomers gather to form bilayer structure [35, 36]. 
Selection of buffer 
In the preparation of ufasomes the widely preferred buffer is tris-
hydroxymethyl aminomethane. Spheres can also be formed in 
solutions like bicarbonate, borate, glycine-hydroxide. Based on the 
solute needed to be incorporated, buffers are selected. In the case of 
vesicular glucose entrapment-ufasomes prepared in bicarbonates 
did not hold glucose and borate preparation due to the formation of 
glucose-buffer complex, it could not be examined for retention [30]. 
Electrolyte  
Formation of ufasomes are mostly inhibited by electrolytes. The 
spheres are exposed to chloride or phosphate buffer solution once 
they are completely stabilized in appropriate buffers and they still 
hold on the occluded glucose [30]. 
Peroxidation  
By peroxidation, when bulky hydrophilic group is introduced would 
cause distortion of the interior of the hydrophobic membrane, and thus 
allowing an easy passageway for water-soluble molecule. Disturbance of 
the normal bilayer arrangement of the fatty acid molecule is the main 
effect of peroxidation on the ufasomes membrane. 
The extent of peroxidation of fatty acid can be affected by the 
method of preparation. During the short time periods needed for 
hand vortexing, no peroxidation occurred. Linoleic acid when 
exposed to 30-W irradiation, it is oxidized in air-saturated buffers at 
0.1 % per m, when treated under more violent ultrasonic 
resuspension. Since 3 ms was the longest exposure period used, even the 
oxidation-sensitive linoleic acid didn’t produce extensive oxidation by 
this method. However, Hicks and Gebicki found that peroxidation of 
linoleic acid membrane can be significantly inhibited by nitroxide 
radicals, butylated hydroxytoluene and α-tocopherol. Lipoxygenase fails 
to peroxidase monoenoic fatty acid since enzyme was not able to induce 
spillage from oleic acid made ufasomes [37, 38]. 
Both enzymatic and non-enzymatic catalytic mechanism are 
involved in Lipid peroxidation (LPO). In non-enzymatic lipid 
peroxidation transition metal ions are the important components 
[39, 40]. In unsaturated lipids, fast rate of peroxidation can be 
catalyzed by only few metal which involves change in valency and 
also which undergoes a single electron transfer. Metals like zinc, 
calcium, magnesium having non-variable valency cannot take part in 
redox-coupled homolysis also influences lipid peroxidation [41]. 
At low concentration (~10-6–10-5) it was manifested that, 
Ca2+triggered Lipid peroxidation in lipid due to its ability to interact 
with negatively charged group of lipids (such as in lecithin-
phosphate group and linolenic acid-carboxyl group), therefore, 
increasing the free Fe2+ion concentration by displacing the bound 
Fe2+ion, that directly take part in Lipid peroxidation catalysis. At high 
concentration (̴10-3), inhibitory effect of Ca2+is dependent on its 
interaction with superoxide anion radicals. Incidentally, biphasic 
action on Lipid peroxidation is not only exerted by Ca2+ions, but 
other cations having higher charge density are also effective in 
releasing Fe2+ion attached to the negatively charged group of lipids 
and furthermore interacting with superoxide free radicals. In the 
absence of Ca2+, it was found that the addition of La3+ions to linolenic 
acid ufasomes in a concentration equivalent to that of Fe2+ions 
stimulated Lipid peroxidation. On the combined action of Ca2+and 
La3+
Recent innovation in conventional ufasomes 
in equimolar concentrations (when the total concentration 
surpasses Fe3+), effect of inhibition of peroxidation was observed in 
linolenic acid [42]. 
New type of fatty acid in ufasome preparation 
Fatty acid cis-4,7,10,13,16,19-docosahexaenoic acid that was known 
to form vesicle by self-assembling around a pH of 8.5 to 9 [45]. 
Extension of pH range 
Usually, narrow range of pH is appropriate for the development of 
vesicles of fatty acid due to the necessity that ionization of only 
about a half of the carboxylic acid is required. Extension of pH range 
can be done using some new approaches as following:  
a) Adding a surfactant or linear alcohol like amphiphilic additives 
with sulfate or sulfonate head group: For instance, constituents of 
decanoic acid, also decanoate make vesicles at a pH range across 6.4 
and 7.8, by the addition of sodium dodecylbenzene sulfonate (SDBS), 
the pH for the formation of vesicles can be brought down slightly at 
a pH of 4.3. Vesicle are also framed underneath pH 6.8 when 
equimolar concentration of dodecylbenzenesulfonate is co-added to 
decanoic acid [27].  
b) Modifying synthetically hydrophilic head group size of fatty acid: 
It was reported that at lower pH vesicles showed improved stability 
by employing fatty acid along an oligo unit (ethylene oxide) 
embedded between carboxyl head group and hydrocarbon chain. 
For the formation of vesicles, lowering the pH range and decreasing 
phase transition temperature (near to Kraft point) is the two effects 
shown by the very polar bulky group [33]. 
Insensitivity toward divalent cation 
Mg2+and Ca2+
Enhancement of stability by crosslinking fatty acid molecules 
by chemical bond 
like divalent cations even at reduced concentrations, 
result in the precipitation of vesicles. Within the presence of ionic 
solute, stabilization of vesicles of fatty acid when glycerol esters of 
fatty acid is added. Study of ternary monoolein mixed sodium oleate 
water system based on cryogenic transmission electron microscopy 
manifested also that unilamellar and multilamellar vesicles 
developed from monoolein and sodium oleate mixture, in addition 
the stable vesicle was mainted over a long period (above one year) 
[44]. 
From anionic gemini surfactant, the development of vesicles with 
carboxyl head group is one example. One more example is fatty acid 
(soap) employed along the sodium-11-acrylamidoundecanoate 
(SAU) which is a polimerizable moiety. It was reported that 
monomeric as well as polymerized sodium-11-
acrylamidoundecanoate form vesicular aggregates by self-
assembling and at high-temperature vesicles from polymeric SAU 
stay stable [45, 46]. 
Mixture of fatty acid/soap vesicle and cationic surfactant-based 
vesicles 
As a mixed vesicles model system, tetradecyltrimethylammonium 
(TTAOH) mixtures and fatty acids were studied. It was discovered 
that when roughly equal concentration of fatty acids and TTAOH 
was mixed, unilamellar as well as multilamellar vesicles were 
formed [47]. Depending upon anionic fatty acid vesicles and 
didodecyldimethyl ammonium bromide (DDAB), major association 
(23 %) of vesicles with opposite charge was reported by Caschera et 
al. [35]. By the association of vesicles of opposite charges evolved a 
reactive intermediate which gradually develops into a bigger single 
vesicle that consists of both the solutes that were sited initially in 
disassociated vesicles and a mixed membrane (comprising of lipids 
of cations as well as anions). By further reaction of the huge vesicle 
results in additional vesicles, in which each consist of the solute that 
is separated initially into two populations of vesicle. This is also 
observed as ‘solute exchange’ mechanism. 
Dynamic nature of ufasomes 
Dynamic characteristics of unsaturated fat vesicles are due to the 
reason that it is made up of amphiphiles having a single chain. 
Dynamic nature that set the unsaturated fat acid vesicles in the 
middle of double-chained amphiphiles that form the conventional 
vesicle and single chained surfactants that form the micelles. The 
fact by simply altering the ionization or protonation ratio of the 
terminal carboxylic acid forms a range of aggregates of fatty acid. 
Chen et al., examined in ufasomes on kinetic formation [48]. The 
formation kinetics of vesicles and micelles from a soap monomer 
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solution or saturated fat was analysed by dialyzing the soap 
monomers or saturated fatty acid across a cellulose acetate 
membrane. Beginning with asymmetric distribution of soap 
monomers or fatty acid in the middle of two chambers splits apart 
by the dialysis membrane, where one of the chambers consist of 
aggregated such as vesicles or micelles and the other chamber 
having only buffer solution, the rate at which equilibrium attained is 
observed. On account of micellar system an equilibrium state was 
promptly acquired (micelles attained in the diffusate chamber and 
the concentration of soap monomer or fatty acid in either of 
chambers became equivalent). But on account of vesicles, 
accomplishment of equilibrium state was seriously impeded (the 
diffusate chamber concentration raised gradually following the 
saturation of solution with monomers). Compared to micelles, 
basically vesicles are made up of a much larger number of 
amphiphiles. Through the dialysis experiment, the obtained result 
interprets that a much greater energy barrier is possessed in the 
development of fatty acid vesicle than the fatty acid monomer (soap) 
generation. A suitable method for the preparation of fatty acid 
vesicle is by taking a buffer solution at intermediate pH and adding 
alkaline soap solution to it. To give an example, a buffer solution of 
pH 8.5 is taken and a concentrated sodium oleate micelles solution is 
added to it, and instinctively due to partial protonation of molecules 
of oleic acid because of fall in pH over 10.5-8.5. Therefore, the 
vesicles produced are polydisperse in lamellarity and also size [27, 
48]. 
Stability consideration in ufasome formulation 
Ufasome membrane connected with the long-term stability is 
highly reliant on the decline in free energy associated with the 
fatty acid-water system. The formation of ufasome membrane is 
not spontaneous as a separate phase is formed by acids at pH 8. 
Under the appropriate condition, even gentle mechanical agitation 
is adequate in the bilayer development. Definitely considerable 
amount of energy released during this process emerges from the 
increased entropy of water that goes along with the hydrophobic 
interactions associated with oriented hydrocarbon chains. In the 
bilayer, the attractive interaction is denied by the ionized carboxyl 
head group that possesses mutual repulsion. Electrostatic 
separation diminish the film stability of fatty acid and may result 
in disruption by diminishing the level of head group separation 
and by the development of stable complexes across the ionized 
and protonated carboxyl head group or by screening of counter 
ions, the charge repulsion can be minimized. Every one of these 
procedures may work in the adjustment in the ufasome membrane 
stability. In the membrane stability favorably, lateral charge 
repulsions are diminished by bringing down the pH that happens 
at the particle surface. Decline in ionization upgrades the stability 
of membrane by various methods. Initially, protonated molecules 
are basically not soluble in water that is in correlation with anions. 
Secondly, there is a decrease in later head group repulsion; in a 
membrane of firmly filled head groups the normal separation of 
charges increased around 40 percentage on the expulsion of every 
subsequent charge bringing about bisect of coulombic repulsions. 
Then, a firmly bound succession of complexes is formed by anions 
(A-) and protonated acid molecules (AH), in which a ratio of 1:1 
complex predominant species. Three contributions constitutes the 
energy required for binding-change in energy emerging from 
hydrophobic interaction, the entropy of demixing related to the 
development of dimers, also decrease in free energy achieved due 
to the development of hydrogen bond within the protonated group 
as well as ionized carboxyl groups. Studies based on interaction in 
carboxylic acid indicated that unusually strong H bond develops 
within–COOH and–COO groups due to the existence of negative 
charge from nearby the hydrogen engaged in bonding. 
Stabilization of ufasome membrane is done by bonding hydrogen 
of the head group with water, formation of the complex among the 
ionized molecule and neutral acid molecules and also as the 
dissociated carboxyl groups get hydrated. Besides, the 
hydrocarbon part of the fatty acids is held together by exactly 
similar dispersion, also the hydrophobic interaction which 
stabilizes the micelles as well as the inner area of the membrane 
[29, 34]. 
Microscopic studies 
The arrangement of constituents of biological membrane-like 
phospholipid, fatty acid was attained from the electron microscopy 
of sectioned vesicular structures. Generally, it was acknowledged, 
although, that essential fixing and staining needs strong chemicals 
that can deform those delicate structure, with subsequent loss of 
definition and development of artifacts. These kinds of issues can be 
diminished by utilizing less brutal strategies. One of the best 
successful technique called freeze-fracture technique, is exerted to 
natural components. Detection of birefringence is relatively less 
harsh technique. Electron microscopy of specimens that are 
negatively stained, as an experiment to study the structure of 
ufasome, indicated that they did not make it through the 
preparatory steps. All efforts taken in staining ufasomes for electron 
microscopy using neutralized potassium phosphotungstate became 
unsuccessful to generate specimen having any interior structure 
[49]. 
Freeze fracturing and etching 
Before anything else the suspension containing ufasomes is 
equilibrated for ten ms with 17 % glycerol prior to freezing. Then 
the suspension of ufasomes is then frozen quickly on to copper 
helmet containing Freon, which later reserved inside liquid nitrogen. 
In Balzers microtome, fracturing is done at pressure 2×10-6
Birefringence  
 torr and 
temperature 110 °C. Temperature is raised to 100 °C for etching for 
about 1 m. After etching, a film of carbon and platinum is 
accumulated over the fracture face up to a thickness of 3 
nanometers and at an angle 45 °. The best strategy employed to 
clean replica is by floating them away from the metal helmet 
towards the water, followed by gently adding methanol until the 
solution become 80 % alcohol. For the removal of all the traces 
associated with fatty acid, it took 30 ms. In electron microscope 
Hitachi HS8, the replicas are then analyzed [50, 51]. Hicks and 
Gebicki reported that the ufasomes developed from oleic acid or 
ufasomes formed from linoleic acid have no dissimilarity in their 
appearance [49]. Since ufasome composition hold large quantity of 
water, ice constitutes most of the freeze fractured face that usually 
possessed an extremely improper surface. In the case of ufasomes 
during etching of surface, especially when ufasomes are pre-
equilibrated in glycerol and in appearance developed a noticeable 
variation amidst ice as well as the particle surface. The outer and 
inner surface of fatty acid that is exposed are smooth, whereas it is 
typically granular in the case of surrounding ice. Also, the space 
between the membrane is also rough, denoting that it comprised of 
water [52-54]. 
The frequency difference of birefringent particles can be elucidated 
by the large instability of inter-membrane distances frequently seen 
in ufasomes. Various forms of birefringence seen in multilamellar 
particles are formed of an intrinsic component that in sign form is 
generally positive and negative. 
From the perpendicularly arranged lipid molecule to the surface of 
the membrane emerges the component containing positive sign and 
negative component owing to parallel orientation of adjacent 
membranes. Reduction in birefringence intensity occurs as distance 
between the neighboring membranes elevates. Freeze-etched 
preparation of ufasome clearly showed that water-filled spheres or 
improper multi-membrane particles are a lot more typical than that 
of symmetrical particles, which would be relied upon to offer strong 
birefringence [55, 49]. 
Recent studies on ufasome for targeted delivery 
Recent studies performed in oleic acid-based ufasomes are 
summarized briefly in a tabulated form (table 2). 
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Table 2: Recent studies done in oleic acid ufasomal preparation 
Drug category Drug name Route of 
administration 







The study revealed that a greater amount of clotrimazole loaded 
ufasomes was accumulated in the skin than the marketed formulation. 
[56] 
 




In vivo study showed prolonged release of the drug and concluded that 
it may be good for treatment of topical infection like candidiasis.  
[57] 
 
 Fluconazole Topical Various studies showed that oleic acid vesicles penetrate stratum 
corneum and retain the drug accumulated and inferred that ufasome is 
a potential carrier topical targeted delivery. 
[58] 
Vasodilator Minoxidil Follicular Study suggests that the vesicular minoxidil gel was 10 fold greater than 




Cinnarizine Nasal The studies that lyophilized ufasomes gel can penetrate deep nasal 
mucosa layer and cinnarizine loaded ufasome vesicle is possible for 
intranasal delivery. 
[60] 
Antiosteoarthritic  Glucose amine 
sulphate 
Topical The drug loaded oleic acid vesicle showed 51 % remission at the end of 
the study and concluded that it can be used as an alternative for topical 
delivery of antiosteoarthritic drug. 
[61] 
 
Comparison of ufasome and liposome 
Comparison of ufasomes with the thoroughly studied vesicular drug 
delivery system liposomes are done based on: [42, 28] 
a) Method of preparation of ufasomes versus liposomes 
Practically almost similar methods can be employed in the preparation 
of ufasomes and liposomes. One interesting dissimilarity is that 
particles of uniform size are not formed by intensive sonication of fatty 
acid dispersion. Rather, there are some evidence which indicates that, 
a clear supersaturated system is formed when oleic acid as well as 
linoleic acid is forced into the solution, and on standing for some time 
the solution turns turbid. Ufasomes retain less solute per unit weight 
of fatty acid that is prepared by sonication. This may be because as the 
sphere has much smaller size which is produced by much drastic 
technique [48]. 
b) pH sensitivity  
Ufasomes when compared to liposomes are relatively more sensitive 
to ionic strength and also the pH of the medium. Whereas, the range 
of conditions that fail in the formation of fatty acid lipid membrane 
are well tolerated by phospholipid vesicles, aside from low ionic 
strength and alkaline pH [27]. 
c) Light scattering property 
Phospholipid vesicles resulted as stronger scatterers per mol material, 
as a result of comparing light scattering property of liposomes and 
ufasomes. It is difficult to produce an equivalent comparison; 
approximately 10-3 molar liposomal suspension possess an 
absorbance of 0.7, whereas similar suspension of ufasomes gives an 
absorbance around 0.2 and the part of the difference in comparison 
may lie in the phospholipid’s relatively large cross-sectional area. 
d) Cross-sectional area 
At 10 to 20 dyne cm-1, the reasonable cross-sectional areas for lecithin 
is 0.8 nm2and for linoleic acid and oleic acid is 0.4 nm2. Therefore, it 
seems such that lecithin forms a membrane double as that of the 
membrane framed from the mol of either oleic acid or linoleic acid. 
e) Solute entrapment capacity 
Both liposomes and ufasomes have same almost the same glucose 
entrapment capacity. Liposomes produced from lecithin with dicetyl 
phosphate and added cholesterol held around 1200 nm glucose/µm 
lipid. The amount was nearly doubled when lecithin is replaced by 
sphingomyelin. In the case of ufasomes, compared to this ufasomes 
can entrap around 450 nm glucose/µm fatty acid. Again, this may be 
because of smaller spheres per mol. 
f) Internal arrangement 
Liposomes are concentric bi-layered microvesicle where the fluid 
compartment is completely encased by a bi-layered membrane 
made up of phospholipids. Ufasomes are closed lipid bilayered 
vesicle composed of fatty acid with their hydrocarbon tails oriented 
along the inside of the membrane and carboxyl groups towards the 
water. 
g) Cost  
Purified diacylglycerol-phospholipids are much expensive than a 
conventional fatty acid. Liposomes are costlier than ufasomes [34]. 
h) Internal absorption  
It has been reported by Patel and Ryman that, in rats, considerably 
lower hypoglycemic effect was shown by orally taken insulin that is 
encapsulated to liposomes than intraperitoneally delivered insulin 
that is encapsulated or free [62]. Entrapment into egg 
phosphatidylcholine-cholesterol liposomes firmly decreased the 
everted jejunum of the rat from carboxyfluorecein absorption and 
slightly raised fluorescein isothiocynate-conjugated dextran 
absorption. Patel et al. also reported that in the dog duodenum on 
administration of liposomal insulin there was an unreproducible 
rise in plasma immunoreactive insulin level. Majority of the studies 
showed unfavorable results and therefore concluded that liposomes 
in practical significance do not hold any absorption promoting effect. 
Murakami et al. reported that when carboxyfluorescein is entrapped 
into ufasomes showed enhanced absorption. Results manifest that 
intestinal degradation of ufasomes due to liberation of fusogenic 
lipid advances drug absorption [62-66]. 
Some of the major characteristics difference between ufasomes and 
liposomes are represented (fig. 3). 
 
 




Vesicular drug delivery systems are gaining popularity in the 
current field because of its site specifically targeted drug delivery 
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and other advantages. Ufasome is a vesicular system as a novel drug 
delivery. They are oleic acid vesicles which is a suspension of closed 
lipid bilayer preparation of stable ufasomes mainly relies on 
appropriate choice of fatty acid, cholesterol quantity, range of the 
pH, buffer and lipoxygenase amount. Recent innovation provides 
opportunities to produce ufasomes with very efficient features such 
as stability considerations, dynamic features and microscopic 
features of ufasomes. Also, they are capable as carriers for oral 
intake of less absorbable drugs and the horizontal transfer of genes 
from plants. The article furthermore provides the difference 
between ufasomes with liposomes. 
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